Early laser photocoagulation treatment as an option in central serous chorioretinopathy

Publication

Early laser photocoagulation treatment as an option in central serous chorioretinopathy

Journal Paper/Review - Sep 1, 2009

Sturm Veit

Citation

Sturm V. Early laser photocoagulation treatment as an option in central serous chorioretinopathy. Ophthalmic Surg Lasers Imaging 2009; 40:453-60.

Type

Journal Paper/Review (English)

Journal

Ophthalmic Surg Lasers Imaging 2009; 40

Publication Date

Sep 1, 2009

Issn Print

1542-8877

Pages

453-60

Brief description/objective

BACKGROUND AND OBJECTIVE
To investigate the effect of early photocoagulation in central serous chorioretinopathy.

PATIENTS AND METHODS
In a prospective study, 15 consecutive patients with central serous chorioretinopathy and single leakage points were treated with photocoagulation between 2 days and 8 weeks after onset of symptoms. The main outcome measures were best-corrected visual acuity and metamorphopsias (Amsler grid) at months 1 and 4 compared with baseline.

RESULTS
Mean visual acuity improved by 1.53 lines 1 month after treatment. The mean squares involved in the Amsler grid were reduced by 2.07 squares. No relapse occurred during the follow-up period.

CONCLUSION
Considering the characteristics of individuals affected by central serous chorioretinopathy, a fast recovery would be advantageous. This study identified early laser photocoagulation in central serous chorioretinopathy as an effective treatment regarding resorption of subretinal fluid, recovery of visual acuity, and improvement of metamorphopsia.